Fw: [StealthVirus-Patient] STEALTH ADAPTED VIRUSES *New Publication*

[Guest guest]

[stealthVirus-Patient] STEALTH ADAPTED VIRUSES *New Publication*

STEALTH ADAPTED VIRUSES:

Their Implication

in a Host of Chronic Illnesses

June/July 2002

Compiled from their website, www.ccid.org, by -Anne Platel,

and printed with permission from the Center for Complex Infectious

Diseases and it's Founder, W. , M.D., Ph.D., the

discoverer of Stealth Viruses.

STEALTH ADAPTED VIRUSES:

Their Implication in a Host of Chronic Illnesses

= = =

WHAT ARE STEALTH ADAPTED VIRUSES?

Viruses are submicroscopic infectious agents that replicate inside

cells. Viral illnesses are normally controlled by the body's immune

system acting primarily through white blood cells called lymphocytes.

These cells recognize certain viral proteins that provide the

antigens targeted by specific lymphocytes, leading to an anti-viral

inflammatory response. Not all viral proteins, however, can function

as antigens for effective anti-viral immunity. Indeed for many

viruses, it has been confirmed that effective immune recognition

develops for only a small fraction of the different proteins encoded

by the virus. Loss of the genes coding these critical antigenic

proteins can allow a virus to essentially go unrecognized by the

cellular immune system. When such viruses have managed to retain the

capacity to damage cells, they can potentially cause a persistent

infection resulting in a prolonged illness and even death. The viral

nature of such an illness is usually overlooked because of the

absence of overt inflammation. Non-inflammatory, atypically

structured, cell-damaging (cytopathic) viruses were initially

identified in patients with Chronic Fatigue Syndrome (CFS), and in

patients with more severe neurological and neuropsychiatric

illnesses. The term " stealth " was introduced both to highlight their

basic property of evading effective immune recognition, and because

they had gone unrecognized by the medical community.

The Center for Complex Infectious Diseases (CCID) is currently

specializing in the detection and characterization of viruses that

have undergone a stealth adaptation to avoid cellular recognition and

elimination by the immune system.

MULTI-SYSTEM ILLNESSES CAUSED BY STEALTH VIRUS INFECTION

It has been scientifically established that stealth viruses

definitely exist. and his colleagues have further argued that

these viruses are at the root of many multi-system illnesses,

especially those diseases in which there is psychological and/or

neurological evidence of brain dysfunction. Stealth viruses have been

found in the blood, cerebrospinal fluid, urine, throat swabs, breast

milk, brain biopsies and tumor samples from patients with various

neurological, psychiatric, auto-immune and neoplastic diseases.

also found that almost 10% of the blood samples obtained from

university students who were donating blood for transfusion, tested

positive for stealth viruses. This poses a risk of stealth virus

infection from the blood of inadequately screened donors.

Animal transmission studies have shown that stealth viruses can

infect animals. In one particular study, stealth virus isolated from

a patient with CFS, and another virus isolated from a patient with

systemic lupus erythematosus (SLE), dramatically altered the behavior

of animals tested in a University setting. Evidence for viral

infection could be found throughout the various organs of the

animals, including the brain.

The reason that most symptoms relate to the brain damage is that,

unlike other organs, the brain uses different separate regions to

carry out its multiple functions. Other organs function more

uniformly. Therefore, limited localized damage in organs other than

the brain can be easily compensated by heightened activity elsewhere

in the same organ. Cross-protecting, functional compensation does not

operate well in the brain; rendering stealth virus infected

individuals especially vulnerable to neuropsychiatric illnesses and

cognitive impairment, making even normal life tasks difficult. All

organs, including the brain, can be indirectly affected, for example,

if the stealth viral damage evokes an autoimmune response. This can

be seen in cases of SLE, multiple sclerosis, thyroid diseases,

rheumatoid arthritis, and many other illnesses.

Cancer is yet another example where damage, even to a single cell,

can result in a life-threatening illness. Stealth virus associated

cancers are especially likely in those patients in whom the cancer

occurs following a long history of CFS-like or some other

neuropsychiatric or autoimmune illness. has completed double

blind studies on patients with multiple myeloma and is currently

working with selected patients with breast, prostate and brain tumors.

The hallmark of stealth virus infection, whether in the tissues of

patients or inoculated animals, includes damage to the cell's

powerhouse, the mitochondria, with a compensatory increase in

cellular fat (lipid). This causes the cells to be starved of the

necessary energy resources needed to perform properly, which is why

stealth virus infected individuals experience post exertion fatigue

and cognitive impairment.

Using the established culture method, has identified stealth

viral infections in most patients currently being diagnosed as having

the CFS. Stealth virus infections are also consistently being found

in patients with other clinically related illnesses such as

fibromyalgia, and Gulf War Syndrome. Clinically, these patients are

similar to those currently labeled as having chronic Lyme disease.

However, since the lipid-laden cells infected with a stealth virus

appear especially favorable to the growth of intracellular bacteria,

including Borrelia burgdorferi, the agent of Lyme disease, it is

possible to have both infections. has seen positive stealth

virus cultures in Lyme disease patients, including many that have

been clinically unresponsive to years of antibiotic therapy.

Stealth virus infections can cover a wide spectrum of illnesses,

which make their detection and acceptance by the medical community

more difficult than if a single virus was being linked to a single

disease. Thus, more research and education on stealth viruses is

urgently needed.

ORIGINS OF STEALTH VIRUSES

The best studied stealth virus unequivocally originated from the type

of virus known to contaminate the kidney cell cultures used to

produce live poliovirus vaccine. Until very recently, polio vaccine

was grown in kidney cells obtained from African green monkeys. As far

back as 1972, it was known that these cultures were contaminated with

monkey cytomegalovirus. Despite the finding of African green monkey-

derived stealth-adapted cytomegalovirus in a patient with CFS and in

another patient with a severe manic depression, Federal authorities

declined to fully sequence the African green monkey simian

cytomegalovirus (SCMV). This task has been undertaken by CCID without

any outside funding.

CCID has also assisted other investigators in documenting the

contamination of early poliovirus vaccines with another Simian Virus

called SV40. Recently reported findings have demonstrated the

persistence of at least a portion of this virus in patients with

lymphoma.

Stealth adaptation has conceivably occurred with numerous types of

viruses, including such entities as Epstein-Barr Virus, human

herpesvirus-6, human cytomegalovirus, hepatitis C virus, SV40 and

parvovirus. Viral cultures, as performed at CCID, provide the most

sensitive test method to screen for all types of stealth-adapted

viruses.

VITERIA - A NEW LIFE FORM

Certain stealth viruses have acquired genes from bacteria and have

been co-designated as viteria, since they contain both viral and

bacterial genes. Researchers at CCID have uncovered disturbing

evidence for this new life form in ongoing studies on the SCMV-

derived stealth virus. DNA sequencing studies on purified virus

showed the unexpected additional presence of modified genes from

Brucella, mycoplasma, Streptococcus and other bacteria. The presence

of bacterial genes in stealth viruses can help explain the misleading

positive test results for various bacteria in stealth virus infected

patients. More importantly, the findings indicate that certain

stealth viruses have managed to breach the normal barrier that

separates human and animal viruses from bacteria. The passage of

stealth viruses through bacteria may have profound consequences to

the genetic stability of bacterial and animal populations. It will

also make the task of controlling the spread of stealth viral

infections so much more difficult.

Could viteria infection explain the rise in unusual illnesses within

our communities? CCID researchers certainly think so. They have

cultured atypical viruses from numerous patients that posed

diagnostic difficulties for their doctors. " There is no doubt that

viteria can cause brain damage leading to learning and behavioral

problems in children, fatigue and depression in adults, and dementia

in the elderly " says Dr. . " Once someone is infected within a

family, it is not uncommon to see other family members, and even

household pets, begin to develop symptoms and to test positive for

viteria. "

Dr. continues, " The growing concern now is evidence that

viteria can acquire genes that cause human and animal cancers. Many

cancer patients will report that well before the cancer developed,

they were aware that something was wrong with their body. Many were

experiencing unusual fatigue, not sleeping well and having

difficulties with daily tasks that required mental effort. Sadly,

many of these same symptoms can be present in other family members,

adding to the emotional and financial difficulties in coping with a

newly diagnosed cancer. Viteria testing in these patients is

necessary to exclude the possibility of infected bacteria causing an

infectious cancer epidemic. If cancer patients are infected, they may

well benefit from anti-stealth virus treatments. "

SCIENTIFICALLY VALID CLINICAL TRIALS

CCID discourages the clinical categorization of chronic fatiguing

neuropsychiatric illnesses into such entities as CFS, fibromyalgia,

depression, schizophrenia, amyotrophic lateral sclerosis,

Parkinson's, Alzheimer's, etc. Patients with these syndrome complexes

should be viewed as potentially having multi-system illnesses due to

persistent stealth viral infections. This realization can lead to a

more comprehensive analysis and understanding of the patientsâ€T

medical, psychological and cognitive problems. It can also lead to

treatment efforts directed towards suppressing the virus and

correcting the associated cellular metabolic disorders. The

integration of laboratory and pharmacy provides a solid foundation

for approved and scientifically valid clinical trials.

A goal of CCID is to establish a national center for the research and

treatment of stealth viruses. The basic premise is that many mental

and other illnesses are the manifestations of a non-inflammatory

stealth virus infection of the brain. Methods to culture stealth

viruses are being taught to other laboratories.

CCID has identified stealth virus inhibitory material, termed Epione,

in the material released from infected cells. Efforts are underway to

purify and characterize this material, and to produce sufficient

quantities for experimental testing both in tissue culture and in

infected animals.

In the interim, it is important to test various patient and control

groups of individuals, to determine the prevalence of stealth virus

infections in patients with various types of illnesses. This will

provide the opportunity to see if many of the commonly used

medications for the particular diseases will affect the levels of

stealth virus infection. In addition, the therapeutic response of

infected patients to currently available anti-viral agents, such as

Ganciclovir, needs to be evaluated in a clinical research setting.

It is proposed that a proportion of both the outpatient and inpatient

facilities at selected hospitals be assigned for clinical stealth

virus research. Partial funding for this activity is expected from

donations and from monies generated from stealth virus and other

clinically justified testing. A proportion of monies generated from

these activities will also be applied to this research program.

HOPE ON THE HORIZON

Stealth virus research has shown that chemokines are likely involved

in the replicative process of stealth viruses and a number of

pharmacological agents, including many herbal medicines, are known to

effect chemokine production. Therefore, various combinations of these

agents or protocols need to be explored to assess their ability to

suppress stealth virus replication. The preliminary indications are

positive, with various collaborating physicians reporting both short

and long-term improvements in their stealth virus infected patients.

These observations need to be confirmed in double blind, placebo

controlled studies.

To that end, Dr. and his colleagues are in the process of

defining various alternative treatment protocols for side by side

comparisons. Information on such protocols is not intended to be

medical advice but rather, for the information of clinicians. Any

treatment using any of the proposed protocols must be done under the

supervision of the patient's doctor in coordination with the CCID.

CCID has outlined the following approach to treating the stealth

virus component of a patient's illness:

i) Strengthen normal neural networks to relieve the neural

dysrhythmias that result in altered personality, impaired thinking

and mood disorders.

ii) Support mitochondrial function since this appears to be the weak

link in the cellsâ€T metabolic functioning.

iii) Suppress stealth virus using various combinations of anti-

chemokine and conventional anti-viral agents and

iv) Search for other potential manifestations of stealth viral

infections, including endocrine auto-immune diseases, cancer, cardiac

disease, coagulation and other problems.

CCID is also currently pursuing the use of various energy medicine

modalities to suppress stealth virus replication and reinvigorate

stealth virus infected cells.

NEED FOR FINANCIAL ASSISTANCE

Stealth virus and SCMV sequencing is a costly undertaking. So too are

the purification and characterization of Epione, and the cost of

clinical trials. Stealth virus infected patients soon struggle to

maintain an income, and may find themselves without resources for

further medical care. This tragedy can be coupled with the

deterioration of the health of other family members. While a spouse

and children may have varying diagnoses, there are common features of

a pervasive family illness that is not yet understood by most

physicians and Public Health authorities. It is of paramount

importance that research on stealth viruses not be stymied for lack

of a public commitment. Before this type of disease strikes you or

your family, please give generous financial support to CCID to expand

their important studies. Tax exempt donations can be made to CCID at

3328 s Avenue, Rosemead CA. 91770. The money will help cover

general expenses or it can be specifically ear marked to the DNA

Sequencing, Epione, Clinical Trials, or Energy Medicine Trust

accounts. Credit card payments can be accepted by phone at (626) 572-

7288.

Individuals wishing to participate in clinical trials or to be tested

for stealth viruses should have their physicians contact CCID for

further details. Your physician should also be referred to the CCID's

web site at www.ccid.org

>---------------------------------------------------------

EDITOR'S NOTES:

1. Patients should visit the CCID website www.ccid.org to learn more,

and pass this article on to their physicians.

2. Dr. Rica Bogdany has been working closely with Dr. and CCID

in testing and treating stealth virus infected patients. She is eager

to share her treatment protocols and outcomes with other physicians

so that they may assist their patients in recovering. ONLY Physicians

may contact her in Orlando, FL. at (407) 859-1699.

-Anne Platel, Publisher & Editor:

The National Inspirer: Enriching Mind Body & Creative Spirit

(904) 491-8676 * chrisplatel@...

For more information regarding Stealth Virus Infections, See also Dr. s

Web Page http://www.ccid.org